Drug Profile
RO 0098557
Alternative Names: RO-00-98557Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Basilea Pharmaceutica
- Class Antifungals; Pyridines; Triazoles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Aspergillosis; Candidiasis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Aspergillosis in Switzerland
- 16 Jul 2016 No recent reports of development identified for preclinical development in Candidiasis in Switzerland
- 15 Nov 2002 Preclinical trials in Aspergillosis in Switzerland (unspecified route)